A Phase 3 interventional study of Atropine sulfate 0.01% and Placebo in Myopia, sponsored by Singapore National Eye Centre. Active, not recruiting at 1 site in Singapore. Open to participants aged 5 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-18.
Sponsored by Singapore National Eye Centre · Phase 3, Interventional, and Treatment
Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.
High risk children (with family history of myopia) with low hyperopia or low myopia will be randomized to atropine or placebo, with 2 -2.5 year treatment and 1 year washout.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's enrollment of 300 is above the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Singapore National Eye Centre is the lead sponsor of 84 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
On Atropine 0.01%
Drug: Atropine sulfate 0.01%
On placebo
Drug: Placebo
On Atropine 0.01% daily or every other day
Drug: Atropine sulfate 0.01%
On placebo
Drug: Placebo
Atropine 0.01%
placebo
Spherical Equivalent
SE
Time frame: 3.5 years
Axial Length
AL
Time frame: 3.5 years
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Singapore National Eye Centre